| 发明名称 |
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION. |
| 摘要 |
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration to the eye. The ophthalmic formulations include a stable liquid formulation and a lyophilizable formulation. Preferably, the protein antagonist has the amino acid sequence shown in SEQ ID NO:4. |
| 申请公布号 |
MX2008016124(A) |
申请公布日期 |
2009.01.20 |
| 申请号 |
MX20080016124 |
申请日期 |
2007.06.14 |
| 申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
DANIEL DIX;ERIC FURFINE;KENNETH S. GRAHAM;KELLY FRYE |
| 分类号 |
A61K9/00;A61K9/19;A61K38/00 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
